You have 9 free searches left this month | for more free features.

Subcutaneous (SC)

Showing 1 - 25 of 7,167

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer Trial in Daejeon (GB-5001A, GB-5001D, Oral cohort)

Recruiting
  • Alzheimer Disease
  • Daejeon, Korea, Republic of
    Chungnam National University Hospital
Nov 17, 2023

Melanoma, Urothelial Carcinoma Trial in Berlin (Nivolumab/rHuPH20, Nivolumab)

Not yet recruiting
  • Melanoma
  • Urothelial Carcinoma
  • Berlin, Germany
    Local Institution - 0001
Aug 9, 2022

Ischemic Stroke Trial in Ramat Gan (talfirastide, Placebo)

Recruiting
  • Ischemic Stroke
  • Ramat Gan, Israel
    Sheba Medical Center
Nov 26, 2023

Healthy Volunteers Trial in Glendale (AZD1163, Placebo)

Not yet recruiting
  • Healthy Volunteers
  • AZD1163
  • Placebo
  • Glendale, California
    Research Site
Oct 23, 2023

Healthy Volunteers Trial in Tempe (Vedolizumab SC)

Completed
  • Healthy Volunteers
  • Vedolizumab SC
  • Tempe, Arizona
    Celerion
Jul 1, 2022

Crohn's Disease Trial in Chicago (Vedolizumab, Adalimumab, Ustekinumab)

Not yet recruiting
  • Crohn's Disease
  • Chicago, Illinois
    University of Chicago Medicine
Sep 13, 2023

Relapsed/Refractory Multiple Myeloma Trial (AMG 701)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • AMG 701
  • (no location specified)
Jun 6, 2022

Metastatic NSCLC Trial (Pembrolizumab coformulated with hyaluronidase, Pemetrexed, Cisplatin)

Not yet recruiting
  • Metastatic Non-small Cell Lung Cancer
  • Pembrolizumab coformulated with hyaluronidase
  • +6 more
  • (no location specified)
Jan 27, 2023

NSCLC With STK11/LKB1 Mutation Trial in New York (Daratumumab and Hyaluronidase-fihj, Pre-Intervention Medication,

Not yet recruiting
  • Non-small Cell Lung Cancer With STK11/LKB1 Mutation
  • Daratumumab and Hyaluronidase-fihj
  • +2 more
  • New York, New York
    NYU Langone Health
Mar 29, 2023

Healthy Volunteer Trial in Anaheim, Miami, Springfield (Aducanumab)

Completed
  • Healthy Volunteer
  • Aducanumab
  • Anaheim, California
  • +2 more
Aug 24, 2022

Progressive Supranuclear Palsy Trial in Seongnam-si, Seoul (GV1001 Placebo, GV1001 0.56mg, GV1001 1.12mg)

Not yet recruiting
  • Progressive Supranuclear Palsy
  • GV1001 Placebo
  • +2 more
  • Seongnam-si, Korea, Republic of
  • +4 more
Apr 19, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab Subcutaneous (SC) Administration, Recombinant Human Hyaluronidase [rHuPH20]) SC

Active, not recruiting
  • Multiple Myeloma
  • Daratumumab Subcutaneous (SC) Administration
  • Recombinant Human Hyaluronidase [rHuPH20]) SC Administration
  • Atlanta, Georgia
  • +11 more
Aug 11, 2022

NSCLC Trial (Tislelizumab IV, Tislelizumab SC, Histology-Based Chemotherapy Doublet)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Tislelizumab IV
  • +2 more
  • (no location specified)
Oct 25, 2023

Crohn's Disease Trial (Risankizumab SC, Placebo for risankizumab)

Not yet recruiting
  • Crohn's Disease
  • Risankizumab SC
  • Placebo for risankizumab
  • (no location specified)
Sep 26, 2023

Chronic Inflammatory Demyelinating Polyneuropathy Trial in Boca Raton, Austin (Batoclimab 680 milligrams (mg) subcutaneous (SC)

Recruiting
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Batoclimab 680 milligrams (mg) subcutaneous (SC) weekly
  • +2 more
  • Boca Raton, Florida
  • +1 more
Jan 31, 2023

Real World Data on Vedolizumab Concentration and Outcomes in

Enrolling by invitation
  • Inflammatory Bowel Diseases
  • +2 more
    • Osijek, Croatia
      Klinički bolnički centar Osijek (University Hospital Center Osij
    Aug 15, 2022

    A 24-month Real Life PErsistence Efficacy and Safety Study in

    Recruiting
    • Inflammatory Bowel Diseases
    • Subcutaneous infliximab CT-P13 Remsima®SC
    • Grenoble, France
      Nicolas Mathieu
    Aug 2, 2022

    Crohn's Disease Trial in Warszawa (CT-P13 SC (Infliximab), Placebo SC)

    Active, not recruiting
    • Crohn's Disease
    • CT-P13 SC (Infliximab)
    • Placebo SC
    • Warszawa, Poland
      WIP Warsaw IBD Point Profesor Kierkus
    Dec 6, 2022

    Advanced Nasopharyngeal Carcinoma Trial in Guangzhou (Toripalimab injection(subcutaneous)/JS001sc, Toripalimab /JS001)

    Recruiting
    • Advanced Nasopharyngeal Carcinoma
    • Toripalimab injection(subcutaneous)/JS001sc
    • Toripalimab /JS001
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Feb 21, 2023

    Contraception Trial in Santo Domingo (TV-46046, Depo-subQ 104, TV-46046 Placebo)

    Completed
    • Contraception
    • Santo Domingo, Dominican Republic
      Teva Investigational Site 1
    Nov 18, 2021

    Myositis Trial (EFG PH20 SC)

    Not yet recruiting
    • Myositis
    • EFG PH20 SC
    • (no location specified)
    Jul 28, 2023

    Healthy Volunteers Trial in Grayslake (risankizumab)

    Completed
    • Healthy Volunteers
    • Grayslake, Illinois
      Acpru /Id# 165737
    Mar 9, 2022

    Moderate Alzheimer's Disease Trial (GV1001, Normal saline)

    Withdrawn
    • Moderate Alzheimer's Disease
    • (no location specified)
    Feb 15, 2022

    Healthy Trial in Edegem (BI 765080)

    Completed
    • Healthy
    • BI 765080
    • Edegem, Belgium
      SGS Life Science Services - Clinical Research
    Mar 23, 2022

    Education Support Program on Medication Adherence in Italian

    Active, not recruiting
    • Rheumatoid Arthritis
      • Brescia, Italy
        Local Institution
      Jan 4, 2022